One of the best parts of warm weather is swapping your boots for sneakers and getting your steps in. But if you've noticed ...
A new study links fatty acid metabolism to rheumatoid arthritis treatment, revealing a natural compound that disrupts ...
Post-acute COVID-19 syndrome is known to be more common among people with systemic autoimmune rheumatic diseases (SARDs), but ...
Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...
P004 represents a first-in-class application of GLP-1 receptor agonism in the intra-articular space, specifically targeting patients with knee osteoarthritis and synovitis who have failed multiple ...
AbbVie files for the FDA approval of Rinvoq in alopecia areata, backed by phase III data showing strong hair regrowth and ...
AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease: North Chicago, Illinois Wednesday, April 29, 2026, 1 ...
AbbVie reported that its JAK inhibitor Rinvoq showed superior efficacy to its TNF inhibitor Humira in rheumatoid arthritis patients who had not responded to prior TNF therapy. The phase 3b/4 ...
In 2021, a woman with severe lupus at University Hospital Erlangen in Germany became the first person to receive CAR-T cell ...
Background Understanding drivers of high healthcare utilisation costs among individuals experiencing first-episode psychosis ...